Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
UBS
Argus Health
Deloitte
Boehringer Ingelheim
Teva
Cipla
Harvard Business School
US Department of Justice
McKesson

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Retroviral protease inhibiting compounds
Abstract:A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.
Inventor(s): Kempf; Dale J. (Libertyville, IL), Norbeck; Daniel W. (Crystal Lake, IL), Sham; Hing L. (Gurnee, IL), Zhao; Chen (Gurnee, IL), Reno; Daniel S. (Kenosha, WI)
Assignee: Abbott Laboratories (Abbott Park, IL)
Filing Date:Apr 06, 1995
Application Number:08/418,056
Claims:1. A process for the preparation of a compound of the formula: ##STR18## wherein R.sub.1 is monosubstituted thiazolyl, monosubstituted oxazolyl, monosubstituted isoxazolyl or monosubstituted isothiazolyl wherein the substituent is selected from C.sub.1 -to-C.sub.6 -loweralkyl;

n is 1, 2 or 3;

R.sub.2 is hydrogen or C.sub.1 -to-C.sub.6 -loweralkyl;

R.sub.3 is C.sub.1 -to-C.sub.6 -loweralkyl;

R.sub.4 and R.sub.4a are independently selected from phenyl, thiazolyl and oxazolyl wherein the phenyl, thiazolyl or oxazolyl ring is unsubstituted or substituted with a substituent selected from

(i) halo,

(ii) C.sub.1 -to-C.sub.5 -loweralkyl,

(iii) hydroxy,

(iv) C.sub.1 -to-C.sub.6 -alkoxy or benzyloxy and

(v) C.sub.1 -to-C.sub.6 -thioalkoxy or benzyl-S-;

R.sub.6 is hydrogen or C.sub.1 -to-C.sub.6 -loweralkyl;

R.sub.7 is thiazolyl, oxazolyl, isoxazolyl or isothiazolyl wherein the thiazolyl, oxazolyl, isoxazolyl or isothiazolyl ring is unsubstituted or substituted with C.sub.1 -to-C.sub.6 -loweralkyl; and

Z is absent, --O--, --S--, --CH.sub.2 -- or --N(R.sub.8)-- wherein R.sub.8 is C.sub.1 -to-C.sub.6 -loweralkyl, C.sub.3 -to-C.sub.7 -cycloalkyl, --OH or --NHR.sub.8a wherein R.sub.8a is hydrogen or C.sub.1 -to-C.sub.6 -loweralkyl; or a pharmaceutically acceptable salt thereof, comprising (a) reacting a compound of the formula: ##STR19## wherein R.sub.4 and R.sub.4a are as defined above with Ti(OR****).sub.4 wherein R**** is C.sub.1 -to-C.sub.6 -loweralkyl, followed by reaction with a compound of the formula: ##STR20## or an activated ester derivative thereof, wherein R.sub.1, R.sub.2, R.sub.3, Z and n are as defined above to give a compound of the formula: ##STR21## and (b) acylation of the product of step (a) with a compound of the formula (R.sub.6)(R.sub.7)CHOC(O)OL wherein L is an activating group for the acylation reaction and wherein R.sub.6 and R.sub.7 are defined as above.

2. The process of claim 1 wherein R.sub.1 is C.sub.1 -to-C.sub.6 -loweralkyl-substituted thiazolyl, R.sub.2 is hydrogen, R.sub.3 is C.sub.1 -to-C.sub.6 -loweralkyl, R.sub.4a and R.sub.4 are phenyl, R.sub.6 is hydrogen, R.sub.7 is thiazolyl and n is 1.

3. The process of claim 1 wherein R**** is isopropyl.

4. The process of claim 1 wherein R.sub.1 is 2-isopropyl-4-thiazolyl, n is 1, R.sub.2 is hydrogen, R.sub.3 is isopropyl, R.sub.4 and R.sub.4a are phenyl, R.sub.6 is hydrogen, R.sub.7 is 5-thiazolyl, Z is --N(CH.sub.3)-- and R**** is isopropyl.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Deloitte
Merck
Queensland Health
Moodys
Healthtrust
Fish and Richardson
Express Scripts
Daiichi Sankyo
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot